Merck has announced that the European Commission has approved KEYTRUDA (pembrolizumab), its anti-PD-1 therapy, for the ...
Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio ...
Healthcare stakeholders are keeping high hopes with the successful results of Sanofi Pasteur's Phase III trial of dengue...
The Indian vaccine industry has been in the past few years following close on the footsteps of the Indian pharma sector....
Singapore: Scientists at Vaccine and Gene Therapy Institute of Florida (VGTI), US, a nonprofit immunological research in...
Singapore: Vaccine firm Imaxio's proprietary pro-immunogenic technology, IMX313, has been administered for the first tim...
According to the International AIDS Vaccine Initiative (IAVI), in September 2009, scientists reported isolation of a pai...
Singapore: Dr Poonam Khetrapal Singh, regional director, WHO South-East Asia, in her message has called for ensuring equ...
Singapore: The Thai HIV vaccine that showed promise in initial clinical trials held in Thailand in 2009, has also exhibi...
Singapore: Though vaccination is considered the most important procedure for healthcare and disease management, it is n...
Singapore: Two new vaccines have been added to Bangladesh's national immunization program- Pneumococcal vaccine (PCV) an...
Singapore: In a bid to increase the penetration of immunization programs in rural areas, the Chinese government recently...
Singapore: A single vaccine that immunizes against all types of influenza may soon be a reality, after a team of scienti...
Singapore: Takeda Pharmaceutical has transferred its license agreement with the Japan Health Sciences Foundation (HS Fou...
Singapore: According to recent reports from the National Health Services of Pakistan, pentavalent vaccine worth nearly $...
Singapore: An experimental Ebola vaccine candidate developed by the Beijing Institute of Biotechnology and the Tianjin C...
Singapore: The China Food and Drug Administration made an announcement that China's top drug authority has licensed a do...
Singapore: Scientists at A*Star's Singapore Immunology Network (SIgN) have discovered a clue that has the potential to c...
